Skip to main content
. 2021 Oct 8;8(6):4693–4700. doi: 10.1002/ehf2.13645

Figure 1.

Figure 1

Cardiac magnetic resonance imaging‐assessed changes in left ventricular mass (A) and left ventricular mass indexed to body surface area (B) from baseline to study endpoint in randomized controlled trials of patients treated with sodium glucose transporter‐2 inhibitor therapy versus placebo.